Ulrich Mansmann

19.6k total citations · 1 hit paper
362 papers, 11.4k citations indexed

About

Ulrich Mansmann is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Ulrich Mansmann has authored 362 papers receiving a total of 11.4k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Oncology, 67 papers in Pulmonary and Respiratory Medicine and 62 papers in Molecular Biology. Recurrent topics in Ulrich Mansmann's work include Colorectal Cancer Screening and Detection (33 papers), Genetic factors in colorectal cancer (32 papers) and Colorectal Cancer Treatments and Studies (26 papers). Ulrich Mansmann is often cited by papers focused on Colorectal Cancer Screening and Detection (33 papers), Genetic factors in colorectal cancer (32 papers) and Colorectal Cancer Treatments and Studies (26 papers). Ulrich Mansmann collaborates with scholars based in Germany, Netherlands and United States. Ulrich Mansmann's co-authors include Christine Adrion, P. Lasjaunias, P. Hermanek, Volker Heinemann, Michael Strupp, G. Nusko, Elske Ammenwerth, Georges Rodesch, Carola Iller and H. Álvarez and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ulrich Mansmann

345 papers receiving 10.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study

2010 486 citations Rolf D. Issels, Lars H. Lindner et al. profile →

Peers

Countries citing papers authored by Ulrich Mansmann

Since Specialization

Citations

This map shows the geographic impact of Ulrich Mansmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrich Mansmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrich Mansmann more than expected).

Fields of papers citing papers by Ulrich Mansmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrich Mansmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrich Mansmann. The network helps show where Ulrich Mansmann may publish in the future.

Co-authorship network of co-authors of Ulrich Mansmann

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrich Mansmann. A scholar is included among the top collaborators of Ulrich Mansmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrich Mansmann. Ulrich Mansmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	ML Auditing and Reproducibility: Applying a Core Criteria Catalog to an Early Sepsis Onset Detection System 2025 ·IEEE Access ·(unknown), Ludwig Christian Hinske, Ulrich Mansmann, (unknown)	0
2	Can German Health Insurance Claims Data Fill Information Gaps in Rare Chronic Diseases: Use Case of Haemophilia A 2024 ·Hämostaseologie ·(unknown), (unknown), Christoph Bidlingmaier, Robert Klamroth, (unknown), Anja Schramm, Ulrich Mansmann, Karin Berger	0
3	Distributed non-disclosive validation of predictive models by a modified ROC-GLM 2024 ·BMC Medical Research Methodology ·(unknown), (unknown), Verena Hoffmann, Bernd Bischl, Ulrich Mansmann	0
4	Addressing treatment switching in the ALTA-1L trial with g-methods: exploring the impact of model specification 2024 ·BMC Medical Research Methodology ·(unknown), Sean McGrath, Robin Ristl, Ulrich Mansmann	1
5	Designing an ML Auditing Criteria Catalog as Starting Point for the Development of a Framework 2024 ·IEEE Access ·(unknown), Ludwig Christian Hinske, Ulrich Mansmann, (unknown)	5
6	Endovascular Treatment for Acute Isolated Internal Carotid Artery Occlusion 2023 ·Clinical Neuroradiology ·Daniel Kaiser, Tilman Reiff, Ulrich Mansmann, (unknown), Davide Strambo, Patrik Michel, Mohamad Abdalkader, Thanh N. Nguyen, Matthias Gawlitza, Markus Möhlenbruch, Peter A. Ringleb, Volker Puetz, Johannes Gerber, Simon Nagel	2
7	Associations of the vasoactive peptides CT-proET-1 and MR-proADM with incident type 2 diabetes: results from the BiomarCaRE Consortium 2022 ·Cardiovascular Diabetology ·(unknown), Veikko Salomaa, Frank Kee, Jochen Seißler, Pekka Jousilahti, Charlotte E. Neville, Cornelia Then, Wolfgang Köenig, Kari Kuulasmaa, Jaakko Reinikainen, Stefan Blankenberg, Tanja Zeller, Christian Herder, Ulrich Mansmann, Annette Peters, Barbara Thorand	2
8	Immune infiltrates in patients with localised high-risk soft tissue sarcoma treated with neoadjuvant chemotherapy without or with regional hyperthermia: A translational research program of the EORTC 62961-ESHO 95 randomised clinical trial 2021 ·European Journal of Cancer ·Rolf D. Issels, Elfriede Noeßner, Lars H. Lindner, M. Schmidt, Markus Albertsmeier, Jean‐Yves Blay, Emanuel Stutz, Yujun Xu, Veit Buecklein, A. Altendorf-Hofmann, Sultan Abdel-Rahman, Ulrich Mansmann, Michael von Bergwelt‐Baildon, (unknown)	16
9	Natriuretic Peptides and Risk of Type 2 Diabetes: Results From the Biomarkers for Cardiovascular Risk Assessment in Europe (BiomarCaRE) Consortium 2021 ·Diabetes Care ·(unknown), Veikko Salomaa, Frank Kee, Simona Costanzo, Stefan Söderberg, Jens Jordan, Pekka Jousilahti, Charlotte E. Neville, Licia Iacoviello, Viktor Oskarsson, Dirk Westermann, Wolfgang Köenig, Kari Kuulasmaa, Jaakko Reinikainen, Stefan Blankenberg, Tanja Zeller, Christian Herder, Ulrich Mansmann, Annette Peters, Barbara Thorand	11
10	Enhanced Recovery after Intensive Care (ERIC): study protocol for a German stepped wedge cluster randomised controlled trial to evaluate the effectiveness of a critical care telehealth program on process quality and functional outcomes 2020 ·BMJ Open ·Christine Adrion, Björn Weiß, Nicolas Paul, Elke Berger, Reinhard Busse, Ursula Marschall, (unknown), Simone Rosseau, Ulrich Mansmann, Claudia Spies	14
11	Meta-analysis of the longevity of commonly used pit and fissure sealant materials 2020 ·Dental Materials ·Jan Kühnisch, (unknown), (unknown), Andreas Keßler, (unknown), Ulrich Mansmann, Roswitha Heinrich‐Weltzien, Reinhard Hickel	23
12	Associations of cardiac stress biomarkers with incident type 2 diabetes and changes in glucose metabolism: KORA F4/FF4 study 2020 ·Cardiovascular Diabetology ·(unknown), Jochen Seißler, Jens Jordan, Wolfgang Rathmann, Wolfgang Köenig, Michael Roden, Ulrich Mansmann, Christian Herder, Annette Peters, Barbara Thorand, Cornelia Then	11
13	Confidence interval estimation for the changepoint of treatment stratification in the presence of a qualitative covariate‐treatment interaction 2019 ·Statistics in Medicine ·Bernhard Haller, Ulrich Mansmann, (unknown), Kurt Ulm, Alexander Hapfelmeier	1
14	Immunological profiling of patients with ulcerative colitis leads to identification of two inflammatory conditions and CD1a as a disease marker 2016 ·Journal of Translational Medicine ·(unknown), (unknown), Ulrich Mansmann, Florian Beigel, Matthias Siebeck, Roswitha Gropp	11
15	Persistence of Driver Mutations during Complete Remission Associates with Shorter Survival and Contributes to the Inferior Outcomes of Elderly Patients with Acute Myeloid Leukemia 2016 ·Haematologica ·Maja Rothenberg‐Thurley, Susanne Amler, Dennis Göerlich, M. C. Sauerland, S. Schneider, Nikola P. Konstandin, Sebastian Schaaf, Aarif M.N. Batcha, Kathrin Bräundl, Bianka Ksienzyk, Evelyn Zellmeier, Ulrich Mansmann, Michael Fiegl, Marion Subklewe, Stefan K. Bohlander, Andreas Faldum, Wolfgang Hiddemann, Karsten Spiekermann, Jan Braess, Klaus H. Metzeler	2
16	Comparing Patient-Derived Xenograft and Computational Response Prediction for Targeted Therapy in Patients of Early-Stage Large Cell Lung Cancer 2015 ·Clinical Cancer Research ·Jian Li, (unknown), Ulrich Mansmann	10
17	Surrogate endpoints in second-line treatment for mCRC: A systematic literature-based analysis from 23 randomised trials 2014 ·Acta Oncologica ·Clemens Gießen, Ruediger P. Laubender, Donna P. Ankerst, Sebastian Stintzing, Dominik Paul Modest, Christoph Schulz, Ulrich Mansmann, Volker Heinemann	16
18	Detection of miR-34a Promoter Methylation in Combination with Elevated Expression of c-Met and β-Catenin Predicts Distant Metastasis of Colon Cancer 2012 ·Clinical Cancer Research ·Helge Siemens, Jens Neumann, René Jackstadt, Ulrich Mansmann, David Horst, Thomas Kirchner, Heiko Hermeking	125
19	Progression-Free Survival as a Surrogate Endpoint for Median Overall Survival in Metastatic Colorectal Cancer: Literature-Based Analysis from 50 Randomized First-Line Trials 2012 ·Clinical Cancer Research ·Clemens Gießen, Ruediger P. Laubender, Donna P. Ankerst, Sebastian Stintzing, Dominik Paul Modest, Ulrich Mansmann, Volker Heinemann	55
20	Fundus Autofluorescence Patterns in the Junctional Zone as Prognostic Determinants for Spread of Geographic Atrophy in Age–related Macular Degeneration (AMD) 2004 ·Investigative Ophthalmology & Visual Science ·Almut Bindewald-Wittich, Joanna Dolar-Szczasny, (unknown), Steffen Schmitz-Valckenberg, (unknown), Claudia N. Keilhauer, Daniel Pauleikhoff, Sebastián Wolf, Ulrich Mansmann, Frank G. Holz	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact